Huntington’s disease is a rare genetic disorder affecting movement, memory, and mood. Here’s what we know—and what’s ahead.

Skyhawk Therapeutics has dosed the first subject in the randomised Phase II/III FALCON-HD trial of the oral small-molecule ...

Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that ...

Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that ...

Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to ...

Transplanting healthy human glial progenitor cells into the brains of adult animal Huntington's disease models not only ...

The Huntington disease Digital Motor Score, derived from smartphone sensor-based motor tests, can improve detection of disease progression.

Five simple smartphone-measured tests of movement control can provide quick and regular insight into the motor function of ...

The Huntington’s disease treatment market is evolving, with novel therapies targeting mHTT and reshaping the future of ...